Startseite Medizin Standard and high dose ergocalciferol regimens for treatment of hypovitaminosis D in epileptic children and adolescents
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Standard and high dose ergocalciferol regimens for treatment of hypovitaminosis D in epileptic children and adolescents

  • Suchavadee Vichutavate , Piradee Suwanpakdee , Napakjira Likasitthananon , Nawaporn Numbenjapon , Charcrin Nabangchang und Voraluck Phatarakijnirund ORCID logo EMAIL logo
Veröffentlicht/Copyright: 4. Oktober 2022

Abstract

Objectives

Children with epilepsy are at increased risk of vitamin D deficiency. We aimed to compare the effect of two ergocalciferol regimens given for 90 days.

Methods

Epileptic patients aged 5–18 years who received at least one antiepileptic drug (AED) for more than 6 months and had serum 25-OHD <30 ng/mL were randomized to receive 20,000 IU/10 d (standard dose, n=41) or 60,000 IU/10 d (high dose, n=41) of oral ergocalciferol. Serum Ca, P, Mg, ALP, iPTH and urine Ca/Cr ratio were measured at baseline and after 90 days of treatment. Change in serum 25-OHD and vitamin D status after treatment was evaluated.

Results

The initial serum 25-OHD in the standard dose and high dose group was 19.5 ± 4.9 and 18.4 ± 4.6 ng/mL, respectively. Serum 25-OHD after treatment was significantly higher in the high dose group (39.0 ± 11.5 vs. 27.5 ± 8.6 ng/mL, p<0.05). The average increase in serum 25-OHD in the high dose and standard dose group was 20.6 ± 11.4 and 7.2 ± 7.5 ng/mL, respectively (p<0.05). Normalized serum 25-OHD was achieved in 80.5% of the high dose group compared to 36.6% of the standard dose group (p<0.05). No adverse events were found. Patients with a BMI Z-score>0 had a 2.5 times greater risk of continued hypovitaminosis D after treatment compared to those with a BMI Z-score<0 (95% CI: 1.0–5.9, p<0.05).

Conclusions

Oral ergocalciferol 60,000 IU/10 d for 90 days was more effective at normalizing serum 25-OHD than 20,000 IU/10 d in epileptic children and adolescents who were receiving AEDs.


Corresponding author: Voraluck Phatarakijnirund, MD, Division of Endocrinology, Department of Pediatrics, Phramongkutklao Hospital and College of Medicine, 315 Ratchawithi Road, Phayathai, Ratchathewi, Bangkok, 10400, Thailand, Phone: +66814318155, E-mail:

Acknowledgments

We are grateful to Chula Kooanantakool for statistic consultation, Thitiwan Simasathien and Warissara Sanor for helping in this study, Professor Somchit Jarurattanasirikul for suggesting and review of manuscript.

  1. Research funding: This study was supported by a grant from Phramongkutklao College of Medicine. The funding organization played no role in the study design; in the collection analysis, and interpretation of data; in writing of the report; or in the decision to submit the report for publication.

  2. Author contributions: Suchavadee Vichutavate: performed investigation, reviewed the medical literature, analysis and interpretation of data and composed the first draft of the manuscript. Piradee Suwanpakdee, Napakjira Likasitthananon, Nawaporn Numbenjapon, Charcrin Nabangchang: helped with the clinical studies of the patients. Voraluck Phatarakijnirund: design of the work, performed and coordinated the investigation, analysis and interpretation of data, manuscript preparation and completion. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study was approved by the Institutional Review Board Royal Thai Army Medical Department.

References

1. Holick, MF, Chen, TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 2008;87:1080S–6S. https://doi.org/10.1093/ajcn/87.4.1080s.Suche in Google Scholar PubMed

2. Rovner, AJ, O’Brien, KO. Hypovitaminosis D among healthy children in the United States: a review of the current evidence. Arch Pediatr Adolesc Med 2008;162:513–9. https://doi.org/10.1001/archpedi.162.6.513.Suche in Google Scholar PubMed

3. Vierucci, F, Pistoia, MD, Fanos, M, Gori, M, Carlone, G, Erba, P, et al.. Vitamin D status and predictors of hypovitaminosis D in Italian children and adolescents: a cross-sectional study. Eur J Pediatr 2013;172:1607–17. https://doi.org/10.1007/s00431-013-2119-z.Suche in Google Scholar PubMed

4. Hocaoğlu-Emre, FS, Sarıbal, D, Oğuz, O. Vitamin D deficiency and insufficiency according to the current criteria for children: vitamin D status of elementary school children in Turkey. J Clin Res Pediatr Endocrinol 2019;11:181–8. https://doi.org/10.4274/jcrpe.galenos.2018.2018.0272.Suche in Google Scholar PubMed PubMed Central

5. Reesukumal, K, Manonukul, K, Jirapongsananuruk, O, Krobtrakulchai, W, Hanyongyuth, S, Chatsiricharoenkul, S, et al.. Hypovitaminosis D in healthy children in Central Thailand: prevalence and risk factors. BMC Publ Health 2015;15:248. https://doi.org/10.1186/s12889-015-1588-6.Suche in Google Scholar PubMed PubMed Central

6. Holick, MF. Vitamin D deficiency. N Engl J Med 2007;357:266–81. https://doi.org/10.1056/nejmra070553.Suche in Google Scholar

7. Adams, JS, Hewison, M. Update in vitamin D. J Clin Endocrinol Metab 2010;95:471–8. https://doi.org/10.1210/jc.2009-1773.Suche in Google Scholar PubMed PubMed Central

8. Holick, MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006;116:2062–72. https://doi.org/10.1172/jci29449.Suche in Google Scholar PubMed PubMed Central

9. Holick, MF. The d-lightful vitamin D for child health. J Parenter Enteral Nutr 2012;36:9S–19S. https://doi.org/10.1177/0148607111430189.Suche in Google Scholar PubMed

10. DeLuca, HF. Overview of general physiologic features and functions of vitamin D. Am J Clin Nutr 2004;80:1689S–96S. https://doi.org/10.1093/ajcn/80.6.1689s.Suche in Google Scholar

11. Shin, YH, Shin, HJ, Lee, YJ. Vitamin D status and childhood health. Korean J Pediatr 2013;56:417–23. https://doi.org/10.3345/kjp.2013.56.10.417.Suche in Google Scholar PubMed PubMed Central

12. Holick, MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S–88S. https://doi.org/10.1093/ajcn/80.6.1678s.Suche in Google Scholar PubMed

13. Heaney, RP. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin Nutr 2004;80:1706S–9S. https://doi.org/10.1093/ajcn/80.6.1706s.Suche in Google Scholar PubMed

14. Misra, M, Pacaud, D, Petryk, A, Collett-Solberg, PF, Kappy, M. Drug and therapeutics committee of the lawson wilkins pediatric endocrine society. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 2008;122:398–417. https://doi.org/10.1542/peds.2007-1894.Suche in Google Scholar PubMed

15. Holick, MF, Binkley, NC, Bischoff-Ferrari, HA, Gordon, CM, Hanley, DA, Heaney, RP, et al.. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30. https://doi.org/10.1210/jc.2011-0385.Suche in Google Scholar PubMed

16. Arundel, P, Ahmed, SF, Allgrove, J, Bishop, NJ, Burren, CP, Jacobs, B, et al.. British paediatric and adolescent bone group’s position statement on vitamin D deficiency. BMJ 2012;345:e8182. https://doi.org/10.1136/bmj.e8182.Suche in Google Scholar PubMed

17. The Society for Adolescent Health and Medicine. Recommended vitamin D intake and management of low vitamin D status in adolescents: a position statement of the society for adolescent health and medicine. J Adolesc Health 2013;52:801–3.10.1016/j.jadohealth.2013.03.022Suche in Google Scholar PubMed

18. Braegger, C, Campoy, C, Colomb, V, Decsi, T, Domellof, M, Fewtrell, M, et al.. Vitamin D in the healthy European paediatric population. J Pediatr Gastroenterol Nutr 2013;56:692–701. https://doi.org/10.1097/mpg.0b013e31828f3c05.Suche in Google Scholar

19. Munns, CF, Shaw, N, Kiely, M, Specker, BL, Thacher, TD, Ozono, K, et al.. Global consensus recommendations on prevention and management of nutritional rickets. J Clin Endocrinol Metab 2016;101:394–415. https://doi.org/10.1210/jc.2015-2175.Suche in Google Scholar PubMed PubMed Central

20. Grossman, Z, Hadjipanayis, A, Stiris, T, Torso, SD, Mercier, JC, Valiulis, A, et al.. Vitamin D in European children-statement from the European academy of paediatrics (EAP). Eur J Pediatr 2017;176:829–31. https://doi.org/10.1007/s00431-017-2903-2.Suche in Google Scholar PubMed

21. Holick, MF. The role of vitamin D for bone health and fracture prevention. Curr Osteoporos Rep 2006;4:96–102. https://doi.org/10.1007/s11914-996-0028-z.Suche in Google Scholar PubMed

22. Nettekoven, S, Strohle, A, Trunz, B, Wolters, M, Hoffmann, S, Horn, R, et al.. Effects of antiepileptic drug therapy on vitamin D status and biochemical markers of bone turnover in children with epilepsy. Eur J Pediatr 2008;167:1369–77. https://doi.org/10.1007/s00431-008-0672-7.Suche in Google Scholar PubMed

23. Shellhaas, RA, Joshi, SM. Vitamin D and bone health among children with epilepsy. Pediatr Neurol 2010;42:385–93. https://doi.org/10.1016/j.pediatrneurol.2009.12.005.Suche in Google Scholar PubMed

24. Verrotti, A, Coppola, G, Parisi, P, Mohn, A, Chiarelli, F. Bone and calcium metabolism and antiepileptic drugs. Clin Neurol Neurosurg 2010;112:1–10. https://doi.org/10.1016/j.clineuro.2009.10.011.Suche in Google Scholar PubMed

25. Harijan, P, Khan, A, Hussain, N. Vitamin D deficiency in children with epilepsy: do we need to detect and treat it? J Pediatr Neurosci 2013;8:5–10. https://doi.org/10.4103/1817-1745.111413.Suche in Google Scholar PubMed PubMed Central

26. Fong, CY, Riney, CJ. Vitamin D deficiency among children with epilepsy in South Queensland. J Child Neurol 2014;29:368–73. https://doi.org/10.1177/0883073812472256.Suche in Google Scholar PubMed

27. Greenway, A, Zacharin, M. Vitamin D status of chronically ill or disabled children in Victoria. J Paediatr Child Health 2003;39:543–7. https://doi.org/10.1046/j.1440-1754.2003.00211.x.Suche in Google Scholar PubMed

28. Samaniego, EA, Sheth, RD. Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol 2007;14:196–200. https://doi.org/10.1016/j.spen.2007.08.006.Suche in Google Scholar PubMed

29. Nicolaidou, P, Georgouli, H, Kotsalis, H, Matsinos, Y, Papadopoulou, A, Fretzayas, A, et al.. Effects of anticonvulsant therapy on vitamin D status in children: prospective monitoring study. J Child Neurol 2006;21:205. https://doi.org/10.2310/7010.2006.00050.Suche in Google Scholar PubMed

30. Gröber, U, Kisters, K. Influence of drugs on vitamin D and calcium metabolism. Derm Endocrinol 2012;4:158–66. https://doi.org/10.4161/derm.20731.Suche in Google Scholar PubMed PubMed Central

31. WHO growth reference data for 5–19 years. 2007 WHO reference. Electronic citation. Available from: http://www.who.int/growthref/en/ [Accessed 24 Aug 2009].Suche in Google Scholar

32. Holick, MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353–73. https://doi.org/10.4065/81.3.353.Suche in Google Scholar PubMed

33. Sonmez, FM, Donmez, A, Namuslu, M, Canbal, M, Orun, E. Vitamin D deficiency in children with newly diagnosed idiopathic epilepsy. J Child Neurol 2015;30:1428–32. https://doi.org/10.1177/0883073814566627.Suche in Google Scholar PubMed

34. Lee, YJ, Park, KM, Kim, YM, Yeon, GM, Nam, SO. Longitudinal change of vitamin D status in children with epilepsy on antiepileptic drugs: prevalence and risk factors. Pediatr Neurol 2015;52:153–9. https://doi.org/10.1016/j.pediatrneurol.2014.10.008.Suche in Google Scholar PubMed

35. Shellhaas, RA, Barks, AK, Joshi, SM. Prevalence and risk factors for vitamin D insufficiency among children with epilepsy. Pediatr Neurol 2010;42:422–6. https://doi.org/10.1016/j.pediatrneurol.2010.03.004.Suche in Google Scholar PubMed PubMed Central

36. Lee, SH, Yu, J. Risk factors of vitamin D deficiency in children with epilepsy taking anticonvulsants at initial and during follow-up. Ann Pediatr Endocrinol Metab 2015;20:198–205. https://doi.org/10.6065/apem.2015.20.4.198.Suche in Google Scholar PubMed PubMed Central

37. Fong, CY, Kong, AN, Poh, BK, Mohamed, AR, Khoo, TB, Ng, RL, et al.. Vitamin D deficiency and its risk factors in Malaysian children with epilepsy. Epilepsia 2016;57:1271–9. https://doi.org/10.1111/epi.13443.Suche in Google Scholar PubMed

38. Paticheep, S, Chotipanich, C, Khusiwilai, K, Wichaporn, A, Khongsaengdao, S. Antiepileptic drugs and bone health in Thai children with epilepsy. J Med Assoc Thai 2015;98:535–41.Suche in Google Scholar

39. Likasitthananon, N, Nabangchang, C, Simasathien, T, Vichutavate, S, Phatarakijnirund, V, Suwanpakdee, P. Hypovitaminosis D and risk factors in pediatric epilepsy children. BMC Pediatr 2021;21:432. https://doi.org/10.1186/s12887-021-02906-7.Suche in Google Scholar PubMed PubMed Central

40. Petty, SJ, Wilding, H, Wark, JD. Osteoporosis associated with epilepsy and the use of anti-epileptics-a review. Curr Osteoporos Rep 2016;14:54–65. https://doi.org/10.1007/s11914-016-0302-7.Suche in Google Scholar PubMed

41. Vestergaard, P. Effects of antiepileptic drugs on bone health and growth potential in children with epilepsy. Paediatr Drugs 2015;17:141–50. https://doi.org/10.1007/s40272-014-0115-z.Suche in Google Scholar PubMed

42. Mikati, MA, Dib, L, Yamout, B, Sawaya, R, Rahi, AC, Fuleihan, GH. Two randomized vitamin D trials in ambulatory patients on anticonvulsants. Neurology 2006;67:2005–14. https://doi.org/10.1212/01.wnl.0000247107.54562.0e.Suche in Google Scholar PubMed

43. Viraraghavan, VR, Seth, A, Aneja, S, Singh, R, Dhanwal, D. Effect of high dose vitamin d supplementation on vitamin d nutrition status of pre-pubertal children on anti-epileptic drugs A randomized controlled trial. Clin Nutr ESPEN 2019;29:36–40. https://doi.org/10.1016/j.clnesp.2018.11.007.Suche in Google Scholar PubMed

44. Cipriani, C, Romagnoli, E, Scillitani, A, Chiodini, I, Clerico, R, Carnevale, V, et al.. Effect of a single oral dose of 600, 000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 2010;95:4771–7. https://doi.org/10.1210/jc.2010-0502.Suche in Google Scholar PubMed

45. Heaney, RP, Recker, RR, Grote, J, Horst, RL, Armas, LA. Vitamin D(3) is more potent than vitamin D(2) in humans. J Clin Endocrinol Metab 2011;96:E447–52. https://doi.org/10.1210/jc.2010-2230.Suche in Google Scholar PubMed

46. Quesada-Gomez, JM, Bouillon, R. Is calcifediol better than cholecalciferol for vitamin D supplementation? Osteoporos Int 2018;29:1697–711. https://doi.org/10.1007/s00198-018-4520-y.Suche in Google Scholar PubMed

47. Ish-Shalom, S, Segal, E, Salganik, T, Raz, B, Bromberg, IL, Vieth, R. Comparison of daily, weekly, and monthly vitamin D3 in ethanol dosing protocols for two months in elderly hip fracture patients. J Clin Endocrinol Metab 2008;93:3430–5. https://doi.org/10.1210/jc.2008-0241.Suche in Google Scholar PubMed

48. Talib, HJ, Ponnapakkam, T, Gensure, R, Cohen, HW, Coupey, SM. Treatment of vitamin D deficiency in predominantly hispanic and black adolescents: a randomized clinical trial. J Pediatr 2016;170:266–72. https://doi.org/10.1016/j.jpeds.2015.11.025.Suche in Google Scholar PubMed PubMed Central

49. Takács, I, Tóth, BE, Szekeres, L, Szabó, B, Bakos, B, Lakatos, P. Randomized clinical trial to comparing efficacy of daily, weekly and monthly administration of vitamin D3. Endocrine 2017;55:60–5. https://doi.org/10.1007/s12020-016-1137-9.Suche in Google Scholar PubMed

50. Niet, SD, Coffiner, M, Silva, SD, Jandrain, B, Souberbielle, JC, Cavalier, E. A randomized study to compare a monthly to a daily administration of vitamin D-supplementation. Nutrients 2018;10:659. https://doi.org/10.3390/nu10060659.Suche in Google Scholar PubMed PubMed Central

51. Vieth, R. Why the optimal requirement for vitamin D3 is probably much higher than what is officially recommended for adults. J Steroid Biochem Mol Biol 2004;89-90:575–9. https://doi.org/10.1016/j.jsbmb.2004.03.038.Suche in Google Scholar PubMed


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpem-2022-0197).


Received: 2022-01-23
Accepted: 2022-09-12
Published Online: 2022-10-04
Published in Print: 2022-11-25

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Effects of exercise combined with diet intervention on body composition and serum biochemical markers in adolescents with obesity: a systematic review and meta-analysis
  4. Mini Review
  5. Effect of stimulants on final adult height
  6. Original Articles
  7. Organic acidemias in the neonatal period: 30 years of experience in a referral center for inborn errors of metabolism
  8. The long-term growth, cost-effectiveness, and glycemic effects of growth hormone therapy on children born small for gestational age over 10 years: a retrospective cohort study
  9. Standard and high dose ergocalciferol regimens for treatment of hypovitaminosis D in epileptic children and adolescents
  10. Children and adolescents with type 1 diabetes mellitus in Nigeria: clinical characteristics and compliance with care
  11. Disordered eating and behaviors among young Egyptians with type 1 diabetes: risk factors and comorbidities
  12. Normal or elevated prolactin is a good indicator to show pituitary stalk interruption syndrome in patients with multiple pituitary hormone deficiency
  13. No pubertal growth spurt, rapid bone maturation, and menarche post GnRHa treatment in girls with precocious puberty
  14. Genetic analysis of failed male puberty using whole exome sequencing
  15. Gender diversity in adolescents with polycystic ovary syndrome
  16. Case Reports
  17. Management challenges of Rabson Mendenhall syndrome in a resource limited country: a case report
  18. Thyroid function tests of iodine deficiency goiter can mimic thyroid hormone resistance alpha
  19. Pseudohypoaldosteronism associated with hypertrophic cardiomyopathy, hypertension and thrombocytosis due to mutation in the ELAC2 gene: a case report
  20. Acromicric dysplasia due to a novel missense mutation in the fibrillin 1 gene in a three-generation family
  21. A case of severe systemic type 1 pseudohypoaldosteronism with 10 years of evolution
  22. Advantages of monitoring rT3 and dividing LT3 dose in the treatment of consumptive hypothyroidism associated with infantile hepatic hemangioma
Heruntergeladen am 11.3.2026 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2022-0197/html
Button zum nach oben scrollen